greeksoup/ stock research

Lemaitre Vascular (LMAT) FY2022 results: revenue $162 million, up 4.7% on the year

Lemaitre Vascular Inc. (LMAT) reported revenue of $162 million for fiscal 2022, the year ended 31 December 2022, up 4.7% on the year before. Net income was $21 million, down 23.3%, and diluted earnings per share $0.93. The figures are the company's own, from the 10-K it filed with the SEC on 1 March 2023.

Revenue
$162 million
+4.7% on the year
FY2015FY2022
Operating margin
16.6%
23.6% a year earlier
FY2015FY2022
Net income
$21 million
-23.3% on the year
FY2015FY2022
Diluted EPS
$0.93
-25.6% on the year
FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue162154129+4.7%
Cost of revenue56.853.044.7+7.0%
Gross profit10510184.6+3.5%
Gross margin64.9%65.7%65.4%
Research and development13.311.810.1+12.7%
Operating income26.836.428.8-26.3%
Operating margin16.6%23.6%22.3%
Interest expense0.02.21.3
Pre-tax income27.534.327.4-19.8%
Income tax6.97.46.1-7.1%
Effective tax rate24.9%21.5%22.4%
Net income20.626.921.2-23.3%
Net margin12.8%17.4%16.4%
Diluted EPS$0.93$1.25$1.04-25.6%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow25.435.134.8-27.7%
Capital expenditure3.24.93.0-33.9%
Free cash flow22.130.231.8-26.7%
Free cash flow margin13.7%19.6%24.6%
Cash from investing-10.4-61.1-52.9
Cash from financing-9.213.732.2
Depreciation and amortisation9.411.18.4-14.8%
Share-based compensation4.23.53.0+19.9%
Buybacks0.60.80.6-20.0%
Dividends paid11.09.37.7+17.7%
Dividend per share$0.50$0.44$0.38+13.6%
Diluted shares, weighted22m21m20m+3.2%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity268254173+5.5%
Debt0.00.038.0
Operating lease liabilities14.714.114.8+4.6%
Other liabilities27.624.627.4+12.1%
Total liabilities and equity310293253+6.0%
Fixed assets17.917.115.0+4.9%
Goodwill65.965.965.90.0%
Intangible assets46.552.758.9-11.7%
Investments63.656.10.2+13.3%
Cash and equivalents19.113.926.8+38.1%
Receivables22.019.619.6+12.3%
Other assets75.467.566.4+11.7%
Total assets310293253+6.0%

10-K for the year ended 31 December 2022, filed 1 March 2023: the filing.